🇺🇸 FDA
Patent

US 7033750

Recombinant P53 adenovirus methods and compositions

expired A61KA61K38/00A61K38/1709

Quick answer

US patent 7033750 (Recombinant P53 adenovirus methods and compositions) held by The Board of Regents of the University of Texas System expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61K38/1709, A61K48/00, A61P